Johannes Gutenberg-Universität Mainz
- 6131/39-0
Spittler, Raphael; Bahlke, Fabian; Hoffmann, Boris Alexander et al.
Durable pulmonary vein isolation but not complex substrate ablation determines the type of arrhythmia recurrence after persistent atrial fibrillation ablationJOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY. 2021
Faehling, Martin; Schumann, Christian; Christopoulos, Petros et al.
Durvalumab after definitive chemoradiotherapy in locally advanced NSCLC: Data of the German EAPDATA IN BRIEF. Bd. 34. 2021
Halazun, Karim J.; Rosenblatt, Russell E.; Mehta, Neil et al.
Dynamic alpha-Fetoprotein Response and Outcomes After Liver Transplant for Hepatocellular CarcinomaJAMA SURGERY. Bd. 156. H. 6. 2021 S. 559-567
Woods, Kevin; Guezguez, Borhane
Dynamic Changes of the Bone Marrow Niche: Mesenchymal Stromal Cells and Their Progeny During Aging and LeukemiaFRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY. Bd. 9. 2021
Woods, Kevin; Guezguez, Borhane
Dynamic Changes of the Bone Marrow Niche: Mesenchymal Stromal Cells and Their Progeny During Aging and LeukemiaFRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY. Bd. 9. 2021
Righesso, L. A. R.; Terekhov, M.; Goetz, H. et al.
Dynamic contrast-enhanced magnetic resonance imaging for monitoring neovascularization during bone regeneration-a randomized in vivo study in rabbitsCLINICAL ORAL INVESTIGATIONS. Bd. 25. H. 10. 2021 S. 5843-5854
Burgmaier, Kathrin; Kilian, Samuel; Arbeiter, Klaus et al.
Early childhood height-adjusted total kidney volume as a risk marker of kidney survival in ARPKDSCIENTIFIC REPORTS. Bd. 11. H. 1. 2021
Burgmaier, Kathrin; Kilian, Samuel; Arbeiter, Klaus et al.
EARLY CHILDHOOD HEIGHT-ADJUSTED TOTAL KIDNEY VOLUME AS A RISK MARKER OF KIDNEY SURVIVAL IN AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE (ARPKD)PEDIATRIC NEPHROLOGY. Bd. 36. H. 10. 2021 S. 3298-3299
Wolf, D; Tüscher, O
Early Diagnosis of Alzheimer's Disease - Blessing or Curse for Patients?AJOB Neurosci. Bd. 12. H. 4. 2021 S. 234-236
Kaehler, Katharina C.; Gutzmer, Ralf; Meier, Friedegrund et al.
Early Exanthema Upon Vemurafenib Plus Cobimetinib Is Associated With a Favorable Treatment Outcome in Metastatic Melanoma: A Retrospective Multicenter DeCOG StudyFRONTIERS IN ONCOLOGY. Bd. 11. 2021